Literature DB >> 6429881

A quick method for screening platelet dysfunctions using the whole blood lumi-aggregometer.

C M Ingerman-Wojenski, M J Silver.   

Abstract

Patients who present with a clinical history suggesting a bleeding disorder are often tested initially for a clotting defect rather than for platelet dysfunction, due to the length of time necessary to complete a platelet function study in platelet-rich plasma. We have developed a sensitive method for measuring platelet aggregation and release of ATP employing the Whole Blood Lumi -Aggregometer. This method makes it possible to quickly detect patients who require further study for possible platelet function disorders such as cyclooxygenase deficiency, storage-pool defect, thrombasthenia, and von Willebrand's disease. The results obtained with this electrical impedance instrument do not differ from those obtained with the conventional optical method. However, it is now possible to recognize a platelet function defect within 30 min of obtaining a 5 ml sample of citrated whole blood. Further, platelets of unusual size or density are not lost to testing through centrifugation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429881

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Effect of prenylated flavonoids and chalcones isolated from Artocarpus species on platelet aggregation in human whole blood.

Authors:  Ibrahim Jantan; Yusyila H Mohd Yasin; Shajarahtunnur Jamil; Hasnah Sirat; Norazah Basar
Journal:  J Nat Med       Date:  2010-03-27       Impact factor: 2.343

2.  Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results.

Authors:  Connie H Miller; Anne S Rice; Katherine Garrett; Sidney F Stein
Journal:  Br J Haematol       Date:  2014-03-12       Impact factor: 6.998

3.  Investigations of Platelet Function in Whole Blood with BAPA as Anticoagulant.

Authors:  Josephine Tabea Tauer; Judith Lohse; Silvia König; Ralf Knöfler
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

4.  The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.

Authors:  R Scherer; M Kabatnik; J Erhard; J Peters
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

5.  Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects.

Authors:  Renli Teng; Kathleen Butler
Journal:  Eur J Clin Pharmacol       Date:  2010-01-21       Impact factor: 2.953

6.  Platelet aggregation inhibitors from Philippine marine invertebrate samples screened in a new microplate assay.

Authors:  Sheila Marie V Pimentel; Zenaida P Bojo; Amy V D Roberto; Jose Enrico H Lazaro; Gina C Mangalindan; Leila M Florentino; Pilar Lim-Navarro; Deniz Tasdemir; Chris M Ireland; Gisela P Concepcion
Journal:  Mar Biotechnol (NY)       Date:  2003 Jul-Aug       Impact factor: 3.619

7.  Effects of dietary palm oil on arterial thrombosis, platelet responses and platelet membrane fluidity in rats.

Authors:  M L Rand; A A Hennissen; G Hornstra
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

8.  The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.

Authors:  M L Jackson; G P Searcy; D W Olexson
Journal:  Can J Comp Med       Date:  1985-07

9.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

10.  Whole blood platelet aggregation and release reaction testing in uremic patients.

Authors:  Jay Zeck; Jason Schallheim; Susie Q Lew; Louis DePalma
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.